HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Abnormal D-dimer after ending anticoagulation raised risk of recurrent VTE
-
- Annual CT screening can detect curable lung cancer in high-risk patients
- Anticancer vaccine protects women from HPV-associated cervical cancer
- Cancer prevention with Cox-2 inhibitors hampered by cardiovascular toxicity
- Gene expression signature of Burkitt’s lymphoma helps predict responders
- Imatinib shows durable long-term response, cardiotoxicity concerns emerge
- Oral iron chelators appear safe, effective and efficient at clearing iron overloads.
- RUTH: Raloxifene cuts breast cancer risk but increases risk of stroke
- V617F-homozygosity common in PV, not essential thrombocythemia
-
- Advances in the treatment of advanced renal cell carcinoma and GIST
- Breast cancer chemotherapy during pregnancy does not preclude healthy birth
- Fondaparinux reduced venous thrombo-embolism after major abdominal surgery
- IMRT reduced radiation skin burn in women with breast cancer
- Sorafenib improves survival by 39% in advanced renal cell carcinoma
- Validating keratinocyte growth factor for alleviating oral mucositis Lisa K. Lohr, PharmD, BCPS, BCOP